CNE100005XY6
CNE100005XY6
CHANGCHUN BCHT BIOTECHNOLOGY CO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 605.072.928 | 1.229.084.097 | 50.8% |
| Cost of Revenue | 160.735.360 | 179.178.526 | 10.3% |
| Gross Profit | 444.337.568 | 1.049.905.572 | 57.7% |
| 660.979.874 | 749.195.877 | 11.8% | |
| Operating Income | -216.642.306 | 300.709.694 | 172.0% |
| Pretax Income | -331.903.613 | 255.772.911 | 229.8% |
| Net Income Common Stockholders | -262.580.724 | 232.093.826 | 213.1% |
| -- | -- | -- | |
| -- | -- | -- |